$1.33 Billion is the total value of BROADWOOD CAPITAL INC's 7 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 28.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MNST | Sell | MONSTER BEVERAGE CORP NEW | $491,768,503 | +0.6% | 8,295,690 | -2.3% | 36.95% | -11.3% |
| STAA | Buy | STAAR SURGICAL CO | $412,215,500 | +25.3% | 10,768,430 | +2.2% | 30.97% | +10.5% |
| AXON | AXON ENTERPRISE INC | $237,808,199 | +21.1% | 760,062 | 0.0% | 17.87% | +6.8% | |
| IWM | ISHARES TRrussell 2000 etf | $119,029,800 | +4.8% | 566,000 | 0.0% | 8.94% | -7.6% | |
| LCTX | Buy | LINEAGE CELL THERAPEUTICS IN | $61,666,057 | +61.9% | 41,666,255 | +19.3% | 4.63% | +42.8% |
| ONCOCYTE CORP | $7,351,563 | +17.2% | 2,509,066 | 0.0% | 0.55% | +3.2% | ||
| New | SERINA THERAPEUTICS INC | $1,147,048 | – | 85,219 | +100.0% | 0.09% | – | |
| AGE | Exit | AGEX THERAPEUTICS INC | $0 | – | -2,997,156 | -100.0% | -0.10% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STAAR SURGICAL CO | 45 | Q2 2024 | 59.1% |
| MONSTER BEVERAGE CORP NEW | 37 | Q2 2024 | 49.7% |
| ISHARES TR | 36 | Q2 2024 | 14.8% |
| ONCOCYTE CORPORATION | 31 | Q2 2023 | 4.6% |
| AXON ENTERPRISE INC | 27 | Q2 2024 | 17.9% |
| BIOTIME INC | 25 | Q2 2019 | 17.8% |
| AGEX THERAPEUTICS INC | 21 | Q4 2023 | 1.5% |
| LINEAGE CELL THERAPEUTICS INC | 20 | Q2 2024 | 5.1% |
| ASTERIAS BIOTHERAPEUTICS INC | 16 | Q4 2018 | 2.9% |
| CYNOSURE INC | 15 | Q4 2016 | 10.4% |
View BROADWOOD CAPITAL INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 4 | 2024-05-13 |
| 4 | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 4 | 2024-01-10 |
| 4 | 2024-01-05 |
| 4 | 2023-11-30 |
View BROADWOOD CAPITAL INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.